Close
4

Bora CDMO Bora CDMO

X

Company profile for Hemofarm A.D.

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Hemofarm’s core activity is production of high-quality, safe, effective and available generic pharmaceutical products by applying high-end technologies. Hemofarm manufactures medicinal products of all pharmaco-therapeutic groups and forms, from simplest to most complex ones: it sells products of 12 (out of 14) pharmaco-therapeutic groups according to the ATC classification, portfolio contains 192 products by INN, with 38...
Hemofarm’s core activity is production of high-quality, safe, effective and available generic pharmaceutical products by applying high-end technologies. Hemofarm manufactures medicinal products of all pharmaco-therapeutic groups and forms, from simplest to most complex ones: it sells products of 12 (out of 14) pharmaco-therapeutic groups according to the ATC classification, portfolio contains 192 products by INN, with 388 forms and dosages, portfolio is focused on most important pharmaco-therapeutic groups, such as products for cardiovascular diseases, antibiotics and neuropsychiatric products, over-the-counter (OTC) products have a leading position in the Serbian pharmaceutical market, with a share exceeding 13%, constant improvement of portfolio with new generations of medicines, development of new segments, primarily oncology. Hemofarm is a leader in the local market of pharmaceuticals, competing against 300 manufacturers and distributors1, with a share of 34% in goods, i.e. 17.5% in value. Business operations within STADA Group open additional possibilities for sales of products to very demanding EU markets. The new strategic portfolio approach has been ‘tailor-made’ to suit the requirements of each region.it sells products of 12 (out of 14) pharmaco-therapeutic groups according to the ATC classification, portfolio contains 192 products by INN, with 388 forms and dosages, portfolio is focused on most important pharmaco-therapeutic groups, such as products for cardiovascular diseases, antibiotics and neuropsychiatric products, over-the-counter (OTC) products have a leading position in the Serbian pharmaceutical market, with a share exceeding 13%, constant improvement of portfolio with new generations of medicines, development of new segments, primarily oncology. Hemofarm is a leader in the local market of pharmaceuticals, competing against 300 manufacturers and distributors1, with a share of 34% in goods, i.e. 17.5% in value. Business operations within STADA Group open additional possibilities for sales of products to very demanding EU markets. The new strategic portfolio approach has been ‘tailor-made’ to suit the requirements of each region.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Hemofarm A.D.
Serbia-big Flag
Country
Country
Serbia
Address
Address
Belgrade put bb , 26300 Vrsac
Telephone
Telephone
+38113803100, +38113804100
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY